|
WO2020187292A1
|
|
2-substituted pyrazoleamino-4-substituted amino-5-pyrimidine formamide compound, composition and use thereof
|
|
TW202041507A
|
|
Acylamino bridged heterocyclic compound, and composition and application thereof
|
|
WO2020103769A1
|
|
Aromatic ring-linked dioxane-quinazoline or -quinoline compounds, compositions and use thereof
|
|
WO2020042972A1
|
|
Urea-substituted aromatic ring-linked dioxane and quinazoline or quinoline compound, composition and application thereof
|
|
WO2019242689A1
|
|
Cyano-substituted pyridine and cyano-substituted pyrimidine compound, and preparation method and application thereof
|
|
CN111836819A
|
|
Arylamine-substituted pyrrolopyrimidine compound, and preparation method and application thereof
|
|
WO2019170086A1
|
|
Acyl-substituted oxazino-quinazoline compound, preparation method therefor, and uses thereof
|
|
WO2019170088A1
|
|
Oxazino-quinazoline and oxazino-quinazoline type compound, preparation method therefor, and uses thereof
|
|
AU2019218187A1
|
|
Dioxinoquinoline compounds, preparation method and uses thereof
|
|
EP3750893A4
|
|
Dioxazoline compound, preparation method therefor, and uses thereof
|
|
WO2019154132A1
|
|
Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof
|
|
WO2019057112A1
|
|
2-substituted pyrazole amino-4-substituted amino-5-pyrimidine formamide compound, composition, and application thereof
|
|
WO2018157730A1
|
|
Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof
|
|
WO2018153293A1
|
|
Dioxanoquinazoline, dioxanoquinazoline-type compound, preparation method therefor and use thereof
|
|
US2020061065A1
|
|
Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof
|
|
AU2016207168A1
|
|
Quinazoline heterocyclic compound as EGFR kinase inhibitor, and preparation and application thereof
|
